Among them, bladder urothelial carcinoma, cholangiocarcinoma, breast invasive carcinoma, COAD, EAC, KIRP, LUSC, PRAD, GBM, HINSC, LIHC, STAD, and UCEC all showed significant levels of DLL3 expression. Here, DLL3 is linked to cholangiocarcinoma.